Advertisement

Picture EBD Group BIO-Europe 2021 Digital BEU2021 650x80
Document › Details

MeiraGTx Holdings plc. (8/7/19). "Press Release: MeiraGTx Reports Second Quarter 2019 Financial Results and Provides Corporate Update". London & New York, NY.

Organisations Organisation MeiraGTx Holdings Plc (NASDAQ: MGTX)
  Group MeiraGTx (Group)
  Organisation 2 Janssen Pharmaceuticals Inc.
  Group Johnson & Johnson (JnJ) (Group)
Products Product AAV-CNGA3 gene therapy (MeiraGTx)
  Product 2 AAV-hAQP1 gene therapy (MeiraGTx)
Index term Index term JnJ–MeiraGTx: gene therapy, 201901– collab r+d + license ww excl $100m upfront + milestones + funding + 20% royalties for inherited retinal diseases
Persons Person Forbes, Alexandria (MeiraGTx 201810 CEO)
  Person 2 Pascale, Christiana (W2O Group 201901 at W2O pure)
     


   
Record changed: 2019-08-13

Advertisement

Picture EBD Group Connector Personal Networking in Life Sciences 650x80

More documents for MeiraGTx (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

Picture Demy-Colton BioFuture 2021 NYC A October 650x80px




» top